Event details
PainChek (ASX:PCK)
Philip Daffas - CEO
An Australian based company that develops pain assessment technologies. PainChek® is a smart-phone based medical device using artificial intelligence to assess and score pain levels in real time and update medical records in the cloud.
Cann Group (ASX:CAN)
Peter Crock - CEO
Cann Group is building a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and for approved overseas export markets.
Oventus Medical (ASX:OVN)
Dr Chris Hart - CEO & Managing Director
Oventus is a Brisbane-based medical device company that is commercialising a unique treatment platform for sleep apnoea and snoring.
Dimerix (ASX:DXB)
Dr Nina Webster - CEO & MD
Dimerix is a clinical-stage biopharmaceutical company developing innovative new therapies in areas with unmet medical needs for global markets.
Microba (Pre-IPO)
Blake Wills - CEO
Microba is an Australian company working to create a community of greater health. Built on leading scientific research, Microba has established itself as a world leader in the analysis of the gut microbiome. Existing investors include Thorney, Perennial Value and Alium.
Antisense Therapeutics (ASX:ANP)
Mark Diamond- CEO & Managing Director
Drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly
Volpara Health Technologies (ASX:VHT)
Dr Ralph Highnam - CEO
Volpara's clinical functions for breast screening clinics provide feedback on breast density, compression, dose, and quality, while its enterprise-wide practice software management helps with productivity, compliance, reimbursement, and patient tracking.
Respiri (ASX:RSH)
Marjan Mikel - CEO & Managing Director
Leads the way in new technologies to better manage asthma, a chronic disease affecting over 330 million people worldwide and growing including the world's first digital wheeze detection and measurement technology.
Oncosil Medical (ASX:OSL)
Daniel Kenny - Managing Director
A medical device company seeking to advance radiation for cancer patients. OncoSil Medical’s lead product, OncoSil™ is a targeted radioactive isotope (Phosphorus-32), implanted directly into a patient’s pancreatic tumours via an endoscopic ultrasound.
Immutep (ASX:IMM)
Marc Voigt - CEO
Immutep is a globally active biotechnology company that is a leader in the development of LAG-3 related immunotherapeutic products for the treatment of cancer and autoimmune disease.
